327 related articles for article (PubMed ID: 28816235)
1. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
3. JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
Guo Z; Hu YH; Feng GS; Valenzuela Ripoll C; Li ZZ; Cai SD; Wang QQ; Luo WW; Li Q; Liang LY; Wu ZK; Zhang JG; Javaheri A; Wang L; Lu J; Liu PQ
Acta Pharmacol Sin; 2023 Sep; 44(9):1777-1789. PubMed ID: 37186122
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of IκBα in cardiomyocytes alleviates hydrogen peroxide-induced apoptosis and autophagy by inhibiting NF-κB activation.
Han M; Chen XC; Sun MH; Gai MT; Yang YN; Gao XM; Ma X; Chen BD; Ma YT
Lipids Health Dis; 2020 Jun; 19(1):150. PubMed ID: 32580730
[TBL] [Abstract][Full Text] [Related]
5. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
[TBL] [Abstract][Full Text] [Related]
6. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
Abdelhamid G; El-Kadi AO
Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
[TBL] [Abstract][Full Text] [Related]
8. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
9. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.
Li Y; Shen D; Tang X; Li X; Wo D; Yan H; Song R; Feng J; Li P; Zhang J; Li J
Toxicol Lett; 2014 May; 226(3):257-63. PubMed ID: 24583048
[TBL] [Abstract][Full Text] [Related]
10. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
Yu SS; Cai Y; Ye JT; Pi RB; Chen SR; Liu PQ; Shen XY; Ji Y
Br J Pharmacol; 2013 Jan; 168(1):117-28. PubMed ID: 22335191
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats.
Gupta S; Young D; Sen S
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H20-9. PubMed ID: 15749748
[TBL] [Abstract][Full Text] [Related]
13. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
14. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy.
Lu J; Sun D; Liu Z; Li M; Hong H; Liu C; Gao S; Li H; Cai Y; Chen S; Li Z; Ye J; Liu P
Transl Res; 2016 Jun; 172():96-112.e6. PubMed ID: 27016702
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress.
Yu XJ; Zhang DM; Jia LL; Qi J; Song XA; Tan H; Cui W; Chen W; Zhu GQ; Qin DN; Kang YM
Toxicol Appl Pharmacol; 2015 May; 284(3):315-22. PubMed ID: 25759242
[TBL] [Abstract][Full Text] [Related]
16. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
17. MG53, A Novel Regulator of KChIP2 and I
Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
[TBL] [Abstract][Full Text] [Related]
18. Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
Zhao L; Wu D; Sang M; Xu Y; Liu Z; Wu Q
Int Immunopharmacol; 2017 Jul; 48():102-109. PubMed ID: 28499193
[TBL] [Abstract][Full Text] [Related]
19. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
20. C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.
Wang PX; Li ZM; Cai SD; Li JY; He P; Huang Y; Feng GS; Luo HB; Chen SR; Liu PQ
Acta Pharmacol Sin; 2017 Sep; 38(9):1257-1268. PubMed ID: 28649129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
